Cargando…

Enhanced Thermal Stability and Reduced Aggregation in an Antibody Fab Fragment at Elevated Concentrations

[Image: see text] The aggregation of protein therapeutics such as antibodies remains a major challenge in the biopharmaceutical industry. The present study aimed to characterize the impact of the protein concentration on the mechanisms and potential pathways for aggregation, using the antibody Fab f...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Cheng, Bye, Jordan W., Lui, Lok H., Zhang, Hongyu, Hales, John, Brocchini, Steve, Curtis, Robin A., Dalby, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155210/
https://www.ncbi.nlm.nih.gov/pubmed/37040431
http://dx.doi.org/10.1021/acs.molpharmaceut.3c00081
_version_ 1785036285093609472
author Zhang, Cheng
Bye, Jordan W.
Lui, Lok H.
Zhang, Hongyu
Hales, John
Brocchini, Steve
Curtis, Robin A.
Dalby, Paul A.
author_facet Zhang, Cheng
Bye, Jordan W.
Lui, Lok H.
Zhang, Hongyu
Hales, John
Brocchini, Steve
Curtis, Robin A.
Dalby, Paul A.
author_sort Zhang, Cheng
collection PubMed
description [Image: see text] The aggregation of protein therapeutics such as antibodies remains a major challenge in the biopharmaceutical industry. The present study aimed to characterize the impact of the protein concentration on the mechanisms and potential pathways for aggregation, using the antibody Fab fragment A33 as the model protein. Aggregation kinetics were determined for 0.05 to 100 mg/mL Fab A33, at 65 °C. A surprising trend was observed whereby increasing the concentration decreased the relative aggregation rate, ln(v) (% day(–1)), from 8.5 at 0.05 mg/mL to 4.4 at 100 mg/mL. The absolute aggregation rate (mol L(–1) h(–1)) increased with the concentration following a rate order of approximately 1 up to a concentration of 25 mg/mL. Above this concentration, there was a transition to an apparently negative rate order of −1.1 up to 100 mg/mL. Several potential mechanisms were examined as possible explanations. A greater apparent conformational stability at 100 mg/mL was observed from an increase in the thermal transition midpoint (T(m)) by 7–9 °C, relative to those at 1–4 mg/mL. The associated change in unfolding entropy (△S(vh)) also increased by 14–18% at 25–100 mg/mL, relative to those at 1–4 mg/mL, indicating reduced conformational flexibility in the native ensemble. Addition of Tween or the crowding agents Ficoll and dextran, showed that neither surface adsorption, diffusion limitations nor simple volume crowding affected the aggregation rate. Fitting of kinetic data to a wide range of mechanistic models implied a reversible two-state conformational switch mechanism from aggregation-prone monomers (N*) into non-aggregating native forms (N) at higher concentrations. k(D) measurements from DLS data also suggested a weak self-attraction while remaining colloidally stable, consistent with macromolecular self-crowding within weakly associated reversible oligomers. Such a model is also consistent with compaction of the native ensemble observed through changes in T(m) and △S(vh).
format Online
Article
Text
id pubmed-10155210
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-101552102023-05-04 Enhanced Thermal Stability and Reduced Aggregation in an Antibody Fab Fragment at Elevated Concentrations Zhang, Cheng Bye, Jordan W. Lui, Lok H. Zhang, Hongyu Hales, John Brocchini, Steve Curtis, Robin A. Dalby, Paul A. Mol Pharm [Image: see text] The aggregation of protein therapeutics such as antibodies remains a major challenge in the biopharmaceutical industry. The present study aimed to characterize the impact of the protein concentration on the mechanisms and potential pathways for aggregation, using the antibody Fab fragment A33 as the model protein. Aggregation kinetics were determined for 0.05 to 100 mg/mL Fab A33, at 65 °C. A surprising trend was observed whereby increasing the concentration decreased the relative aggregation rate, ln(v) (% day(–1)), from 8.5 at 0.05 mg/mL to 4.4 at 100 mg/mL. The absolute aggregation rate (mol L(–1) h(–1)) increased with the concentration following a rate order of approximately 1 up to a concentration of 25 mg/mL. Above this concentration, there was a transition to an apparently negative rate order of −1.1 up to 100 mg/mL. Several potential mechanisms were examined as possible explanations. A greater apparent conformational stability at 100 mg/mL was observed from an increase in the thermal transition midpoint (T(m)) by 7–9 °C, relative to those at 1–4 mg/mL. The associated change in unfolding entropy (△S(vh)) also increased by 14–18% at 25–100 mg/mL, relative to those at 1–4 mg/mL, indicating reduced conformational flexibility in the native ensemble. Addition of Tween or the crowding agents Ficoll and dextran, showed that neither surface adsorption, diffusion limitations nor simple volume crowding affected the aggregation rate. Fitting of kinetic data to a wide range of mechanistic models implied a reversible two-state conformational switch mechanism from aggregation-prone monomers (N*) into non-aggregating native forms (N) at higher concentrations. k(D) measurements from DLS data also suggested a weak self-attraction while remaining colloidally stable, consistent with macromolecular self-crowding within weakly associated reversible oligomers. Such a model is also consistent with compaction of the native ensemble observed through changes in T(m) and △S(vh). American Chemical Society 2023-04-11 /pmc/articles/PMC10155210/ /pubmed/37040431 http://dx.doi.org/10.1021/acs.molpharmaceut.3c00081 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Zhang, Cheng
Bye, Jordan W.
Lui, Lok H.
Zhang, Hongyu
Hales, John
Brocchini, Steve
Curtis, Robin A.
Dalby, Paul A.
Enhanced Thermal Stability and Reduced Aggregation in an Antibody Fab Fragment at Elevated Concentrations
title Enhanced Thermal Stability and Reduced Aggregation in an Antibody Fab Fragment at Elevated Concentrations
title_full Enhanced Thermal Stability and Reduced Aggregation in an Antibody Fab Fragment at Elevated Concentrations
title_fullStr Enhanced Thermal Stability and Reduced Aggregation in an Antibody Fab Fragment at Elevated Concentrations
title_full_unstemmed Enhanced Thermal Stability and Reduced Aggregation in an Antibody Fab Fragment at Elevated Concentrations
title_short Enhanced Thermal Stability and Reduced Aggregation in an Antibody Fab Fragment at Elevated Concentrations
title_sort enhanced thermal stability and reduced aggregation in an antibody fab fragment at elevated concentrations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155210/
https://www.ncbi.nlm.nih.gov/pubmed/37040431
http://dx.doi.org/10.1021/acs.molpharmaceut.3c00081
work_keys_str_mv AT zhangcheng enhancedthermalstabilityandreducedaggregationinanantibodyfabfragmentatelevatedconcentrations
AT byejordanw enhancedthermalstabilityandreducedaggregationinanantibodyfabfragmentatelevatedconcentrations
AT luilokh enhancedthermalstabilityandreducedaggregationinanantibodyfabfragmentatelevatedconcentrations
AT zhanghongyu enhancedthermalstabilityandreducedaggregationinanantibodyfabfragmentatelevatedconcentrations
AT halesjohn enhancedthermalstabilityandreducedaggregationinanantibodyfabfragmentatelevatedconcentrations
AT brocchinisteve enhancedthermalstabilityandreducedaggregationinanantibodyfabfragmentatelevatedconcentrations
AT curtisrobina enhancedthermalstabilityandreducedaggregationinanantibodyfabfragmentatelevatedconcentrations
AT dalbypaula enhancedthermalstabilityandreducedaggregationinanantibodyfabfragmentatelevatedconcentrations